




Reported STDs in the United States, 2016 
High Burden of STDs Threaten Millions of Americans 
STDs are a substantial health challenge facing the United 
States. CDC estimates that nearly 20 million new sexually 
transmitted infections occur every year, accounting for 
almost $16 billion in health care costs annually. Many 
cases of chlamydia, gonorrhea, and syphilis continue to 
go undiagnosed and unreported, and data on several 
additional STDs – such as human papillomavirus and 
herpes simplex virus, are not routinely reported to CDC. 
As a result, national surveillance data captures only a 
fraction of America’s STD burden. However, the data 
presented in the 2016 STD Surveillance Report provide 
important insight into the scope, distribution, and trends 
in STD diagnoses in the country.
STD Prevention Challenges
Maintaining and strengthening core prevention 
infrastructure is essential to mounting an effective 
national response. Limited resources make it challenging 
to quickly identify and treat STDs. More than half of state 
and local STD program budgets have been cut in recent 
years – resulting in staff layoffs, reduced clinic hours, and 
increased patient co-pays that can limit access to essential 
diagnosis and treatment services. 
Antibiotics can cure chlamydia, gonorrhea, and syphilis. 
However, left untreated, they put men, women, and infants 
at risk for severe, lifelong health outcomes like chronic 
pain, severe reproductive health complications, and HIV. 
People who cannot get STD care remain vulnerable to short- and long-term health consequences and are more likely 
to transmit infections to others – further compounding America’s STD burden. 
Some Groups Are Uniquely Susceptible to the Health Consequences of STDs
Chlamydia can cause lifelong damage to young women 
Chlamydia is the most commonly reported STD, with approximately 1.6 million cases reported in 2016. Young 
women (ages 15-24) account for nearly half (46 percent) of reported cases and face the most severe consequences 
of an undiagnosed infection. Untreated STDs, like chlamydia and gonorrhea, put women at increased risk for pelvic 
inflammatory disease which may result in chronic pelvic pain, infertility, and potentially a life-threatening ectopic 
pregnancy. It is estimated that undiagnosed STDs cause infertility in more than 20,000 women each year.
STDs in the United States
 
More than 2 million cases of the three nationally 
reported STDs – chlamydia, gonorrhea, and syphilis 
– were reported in the United States in 2016, the 
highest number ever.
     Chlamydia 
1,598,354
Rate per 100,000 people: 497
     Gonorrhea 
468,514 
Rate per 100,000 people: 146
     Syphilis (primary and secondary)  
27,814   
Rate per 100,000 people: 9 
     Syphilis (congenital)
628    
Rate per 100,000 live births: 16 
   
   
Cases Reported in 2016: 
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
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Troubling rise in syphilis among women and newborns 
While syphilis was nearly eliminated a decade ago, today it is  
on the rise.  Rates of primary and secondary syphilis, the most 
infectious stages of the disease, increased 18 percent from 
2015 (approximately 7 cases per 100,000 people) to 2016 
(approximately 9 per 100,000 people).  
Increasing rates of syphilis among women has led to a sharp 
rise in congenital syphilis – which occurs when syphilis passes 
from mother to baby during pregnancy. More than 600 cases 
of congenital syphilis were reported in 2016, which resulted in 
a number of deaths and severe health complications among 
newborns. The disease is preventable through routine screening 
and timely treatment for syphilis among pregnant women.
 
















From 2015 to 2016, rates of syphilis increased: 
Among women 
     By 36 percent
      From 1 case per 100,000 women in 2015 to 
2 per 100,000 women in 2016
Among newborns (congenital syphilis)
     By 28 percent
      From 12 cases per 100,000 live births in 
2015 to 16 per 100,000 live births in 2016
STDs accelerating among men, particularly gay and bisexual men 
Men accounted for more than
89 percent (24,724) of all 
primary and secondary syphilis 
cases in 2016.
Rates increased among men by 
15 percent – from 14 cases per 
100,000 men in 2015 to 16 per 
100,000 men in 2016.
Gay, bisexual and other men 
who have sex with men (MSM)* 
accounted for 81 percent (16,155) 
of male cases where the sex of the 
sex partner is known in 2016 and 
over half of primary and secondary 
syphilis cases overall. 
If not adequately treated, syphilis places a person at increased risk for HIV. CDC estimates about half of MSM who have 
syphilis also have HIV.
While gonorrhea increased among men and women in 2016, the steepest increases were seen among men (22 percent) – 
from 140 cases per 100,000 men in 2015 to 171 cases per 100,000 men in 2016. Research suggests that reported cases of 






gonorrhea have increased among MSM in recent years. The rise in gonorrhea nationally is particularly alarming in light of the 
growing threat of drug resistance to the last remaining recommended gonorrhea treatment.
While medication for gonorrhea has been available for decades, the bacteria has grown resistant to nearly every drug 
ever used to treat it. In the United States today, only one recommended treatment option remains – a combination of 
the antibiotics azithromycin and ceftriaxone.
What Can Be Done?
Turning back the rise in STDs will require renewed commitment from all players:
CDC uses national level information to detect and rapidly respond to evolving threats, trains frontline health workers 
and provides STD prevention resources to state and local health departments.
State and local health departments should direct resources to STD investigation and clinical service infrastructure 
for rapid detection and treatment for people living in areas hardest hit by the STD epidemic.
Providers should make STD screening and timely treatment a standard part of medical care, especially for pregnant 
women and MSM. They should also try to seamlessly integrate STD screening and treatment into prenatal care, as 
well as HIV prevention and care services to leverage PrEP clinical guidelines.
Everyone should talk openly about STDs, get tested regularly, and reduce risk by using condoms or practicing mutual 
monogamy if sexually active.
STD Screening is Critical:
If you are sexually active, be sure to talk to your healthcare provider about STD testing and which tests  
may be right for you.
     
Women: 
      If you are a sexually active woman younger than 25,  
or have risk factors such as new or multiple sex 
partners, you should request annual chlamydia and 
gonorrhea tests. If you have never been tested for  
HIV, you should request an HIV test.  
      If you are a pregnant woman, you should request 
syphilis, HIV, chlamydia, and hepatitis B tests early in 
your pregnancy. If you are younger than 25 or have 
new or multiple sex partners, you should also request 
chlamydia and gonorrhea testing early in pregnancy. 
     
     
     
     
Gay and bisexual men:
If you are a sexually active MSM, you should 
request tests for syphilis, chlamydia, gonorrhea, 
and HIV at least once a year. More frequent 
STD testing , such as every 3-6 months, is 
recommended for men at high risk, including 
men who have multiple sex partners. 
If you are a member of the news media, please visit www.cdc.gov/nchhstp/Newsroom or contact the 
News Media Line at CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention: 
404-639-8895 or NCHHSTPMediaTeam@cdc.gov.
Other information requests may be directed to the Division of STD Prevention (www.cdc.gov/std) or the 
CDC-INFO Contact Center: 800-CDC-INFO (800-232-4636).
This fact sheet summarizes data on chlamydia, gonorrhea, and syphilis published in CDC’s annual report, Sexually Transmitted Disease Surveillance, 2016  
(available at www.cdc.gov/std/stats). The data are based on state and local STD case reports from a variety of private and public sources.
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